Help us: Donate
Follow us on:



Arkadi Mazin

Arkadi Mazin

About Arkadi Mazin

Arkadi is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. He strongly believes that life extension is an achievable and noble goal that has yet to take its rightful place on the very top of our civilization’s agenda – a situation he is eager to change.

Related Organizations

Articles from this author

Aging timeline
Using Peter Pan, Wolverine, and a powerful economic model, a trio of prominent scientists argues that slowing aging can bring gargantuan economic benefits – an order of magnitude bigger than previously thought [1]. The marriage of economics and geroscience The paper, published in Nature Aging, looks rather unusual. It is co-authored by one of the...
Time restricted eating
Scientists have shown in mice that long-term caloric restriction can attenuate age-related immunosenescence on par with antibody-mediated clearance of senescent T-cells. On top of that, caloric restriction predictably improved glucose tolerance and lowered inflammation [1]. Senescent cells: inflamed and half-dead Immunosenescence is an umbrella term for a variety of largely detrimental changes that our immune...
Nir Barzilai Interview about metformin and longevity.
Dr. Nir Barzilai is one of the leading experts in geroscience, with more than 25 years of longevity research under his belt. He is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the author of the book Age Later. He is also the leading researcher of TAME,...
Quantum computer
With a new announcement from IBM and Germany’s Fraunhofer Institute, the era of quantum computing has finally arrived in Europe. Can its advance speed up the discovery of new drugs? Europe joins the race Despite being a research and manufacturing powerhouse, Germany, like Europe as a whole, has been lagging behind in what is probably...
Magnifying glass on cancer
Biotech company GRAIL made history earlier this month when it introduced the first commercially available multi-cancer blood test. The test is based on analyzing tumor DNA in circulation and could be a game-changer in the field of cancer diagnostics, especially if the company continues to improve it. Discovering cancer early Medicine has made great strides...
computational biology
In a preprint paper, scientists from Calico, Google’s longevity research behemoth, suggest that contrary to our previous understanding, transient reprogramming of cells using Yamanaka factors involves suppressing cellular identity, which may open the door to carcinogenic mutations. They also propose a milder reprogramming method inspired by limb regeneration in amphibians [1]. Rejuvenation that can give...